Advanced search
Publication Cover
Renal Failure Volume 31, 2009 - Issue 8
Submit an article Journal homepage
1,942
Views
8
CrossRef citations to date
0
Altmetric
Case Reports

Acute Kidney Injury in Patients with Inactive Cytochrome P450 Polymorphisms

Nelson Leung Mayo Clinic Rochester, Division of Nephrology and Hypertension, Rochester, Minnesota, USACorrespondence[email protected]
,
Alfonso Eirin Mayo Clinic Rochester, Division of Nephrology and Hypertension, Rochester, Minnesota, USA
,
Maria V. Irazabal Mayo Clinic Rochester, Division of Nephrology and Hypertension, Rochester, Minnesota, USA
,
Daniel E. Maddox Mayo Clinic Rochester, Division of Allergic Diseases, Rochester, Minnesota, USA
,
Heidi D. Gunderson Mayo Clinic Rochester, Department of Pharmacy, Rochester, Minnesota, USA
,
Fernando C. Fervenza Mayo Clinic Rochester, Division of Nephrology and Hypertension, Rochester, Minnesota, USA
&
Vesna D. Garovic Mayo Clinic Rochester, Division of Nephrology and Hypertension, Rochester, Minnesota, USA
 show all
Pages 749-752 | Received 16 Apr 2009, Accepted 17 May 2009, Published online: 09 Oct 2009

REFERENCES

  • Uchino S, Kellum JA, Bellomo R, Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA. 2005 Aug 17;294(7):813–818.
  • Mehta RL, Pascual MT, Soroko S, Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int. 2004 Oct;66(4):1613–1621.
  • Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med. Apr 2008 ;36(4 Suppl.):S216–S223.
  • Cameron JS. Allergic interstitial nephritis: Clinical features and pathogenesis. Q J Med. 1988 Feb;66(250):97–115.
  • Davison AM, Jones CH. Acute interstitial nephritis in the elderly: A report from the UK MRC Glomerulonephritis Register and a review of the literature. Nephrol Dial Transplant. 1998;13(Suppl. 7):12–16.
  • Rossert J. Drug-induced acute interstitial nephritis. Kidney Int. 2001 Aug;60(2):804–817.
  • Michel DM, Kelly CJ. Acute interstitial nephritis. J Am Soc Nephrol. 1998 Mar;9(3):506–515.
  • McRae D, Kaplan B, Meyer C. Tubulointerstitial nephritis. In Barratt T, Avner E, Harmon W ( eds.). Pediatric nephrology. Baltimore: Lippincott Williams & Wilkins; 1999:823–834.
  • Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med. 2005 May 26;352(21):2211–2221.
  • Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet. 2002 Oct 12;360(9340):1155–1162.
  • Rogers JF, Nafziger AN, Bertino JSJr.. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs. Am J Med. 2002 Dec 15;113(9):746–750.
  • Meyer UA. Pharmacogenetics and adverse drug reactions. Lancet. 2000 Nov 11;356(9242):1667–1671.
  • Nakamura K, Yokoi T, Inoue K, CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine H1 antagonist promethazine in human liver microsomes. Pharmacogenetics. 1996 Oct;6(5):449–457.
  • Scordo MG, Caputi AP, D'Arrigo C, Fava G, Spina E. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharmacol Res. 2004 Aug;50(2):195–200.
  • Polgar T, Menyhard DK, Keseru GM. Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets. J Comput Aided Mol Des. 2007 Sep;21(9):539–548.
  • Goldstein JA. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol. 2001 Oct;52(4):349–355.
  • Bertilsson L, Henthorn TK, Sanz E, Tybring G, Sawe J, Villen T. Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype. Clin Pharmacol Ther. 1989 Apr;45(4):348–355.
  • Chang M, Dahl ML, Tybring G, Gotharson E, Bertilsson L. Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: Comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype. Pharmacogenetics. 1995 Dec;5(6):358–363.
  • de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem. 1994 Jun 3;269(22):15419–15422.
  • Nebert DW, Adesnik M, Coon MJ, The P450 gene superfamily: Recommended nomenclature. DNA. 1987 Feb;6(1):1–11.
  • Berruti V, Salvidio G, Saffioti S, Noramidopyrine (metamizol) and acute interstitial nephritis. Nephrol Dial Transplant. 1998 Aug;13(8):2110–2112.
  • Haydar AA, Hujairi N, Kirkham B, Hangartner R, Goldsmith DJ. Chronic overdose of leflunomide inducing interstitial nephritis. Nephrol Dial Transplant. 2004 May;19(5):1334–1335.
  • Gonzalez E, Gutierrez E, Galeano C, Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 2008 Apr;73(8):940–946.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.